Polyamine biosynthesis dysregulation in Alzheimer's disease and Down syndrome cellular models
Paredes, D.; Sola, A.; Sandberg, A.; Pham, C.; Revier, A.; Hebinck, M.; Penney, A.; Caviedes, P.; Kumar, S.; Granholm, A.-C.; Linseman, D.
Show abstract
BACKGROUNDIndividuals with Down Syndrome (DS) frequently develop early onset Alzheimers disease (AD) with pathological hallmarks closely resembling AD due to several triplicated genes on chromosome 21. Polyamines are small, organic molecules that play a pivotal role for growth and differentiation, and a dysregulation of polyamine pathways is implicated in AD pathology. However, their role in DS-associated AD is unclear. METHODSWe analyzed polyamines and their metabolite levels in mouse hippocampal cells and human DS-AD and AD hippocampal tissue and assessed the effects of the ODC inhibitor difluoromethylornithine (DFMO) on A{beta}42 aggregation and protein expression in DS fibroblasts. RESULTSAmyloid-{beta}42 increased polyamine levels via ornithine decarboxylase (ODC) activation in a dose-dependent manner. DFMO reduced A{beta}42 aggregation, decreased amyloid precursor protein (APP) levels, and normalized proteins linked to AD pathology in DS fibroblasts. Polyamine levels were elevated in DS-AD hippocampal tissue, with colocalization of ODC and A{beta}42 aggregates. CONCLUSIONThese findings suggest that polyamine biosynthesis may exacerbate A{beta}42 toxicity and APP expression, contributing to AD progression in DS. The ability of DFMO to reduce A{beta}42 aggregation and restore protein homeostasis presents the polyamine pathway as a therapeutic target for DS-AD management.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Sensitive detection and propagation of brain-derived tau assemblies in HEK293 based wild-type tau seeding assays 95%
- The eIF2α kinase HRI triggers the autophagic clearance of cytosolic protein aggregates 94%
- Tau regulates Arc stability in neuronal dendrites via a proteasome-sensitive but ubiquitin-independent pathway 94%
Similar papers in this journal
- Suppression of amyloid-β secretion from neurons by cis-9, trans-11-octadecadienoic acid, an isomer of conjugated linoleic acid 96%
- A validated quantitative method for the assessment of neuroprotective barrier impairment in neurodegenerative disease models 94%
- Antagonists targeting eEF2 kinase rescue multiple aspects of pathophysiology in Alzheimer's disease model mice 94%
Similar papers in this journal
- The orphan drug dichloroacetate reduces amyloid beta-peptide production whilst promoting non-amyloidogenic proteolysis of the amyloid precursor protein 97%
- Queuine, a bacterial derived hypermodified nucleobase, shows protection in in vitro models of neurodegeneration 97%
- Cholinergic-like neurons carrying PSEN1 E280A mutation from familial Alzheimers disease reveal intraneuronal Abeta42 accumulation, hyperphosphorylation of TAU, oxidative stress, apoptosis and Ca2+ flux dysregulation: Therapeutic implications 95%
Similar papers in this journal
- Live cell imaging of single neurotrophin receptor molecules on human neuron in Alzheimer's disease 95%
- Anti-inflammatory treatment with FTY720 starting after onset of symptoms reverses synaptic and memory deficits in an AD mouse model 94%
- Arginase Inhibition Supports Survival and Differentiation of Neuronal Precursors in Adult Alzheimer's Disease Mice 94%
Similar papers in this journal
- Alzheimers Disease risk modifier genes do not impact tau aggregate uptake, seeding or maintenance in cell models 93%
- An Enzyme-Linked Immunosorbent Assay (ELISA)-based Activity Assay for AMP-Activated Protein Kinase (AMPK) 90%
- Downregulation of O-GlcNAcylation enhances etoposide-induced p53-mediated apoptosis in HepG2 human liver cancer cells 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.